相关产品推荐更多 >

DiTagTM pH sensitive IgG labeling reagent plus,orb1826357,Biorbyt
¥10881
mmu-miR-7655-3p miRNA Agomir,orb1917204,Biorbyt
¥5499
mmu-miR-6408 miRNA Agomir,orb1917744,Biorbyt
¥5499
TRPA1-IN-2,orb1819093,Biorbyt
¥1170![N3-(2S)-[2-(tert-Butoxycarbonyl)amino-3-(tert-butoxy carbonyl)]propyluridine,orb1908300,Biorbyt](https://img1.dxycdn.com/p/s14/2026/0807/318/2536344336576555802.jpg!wh200)
N3-(2S)-[2-(tert-Butoxycarbonyl)amino-3-(tert-butoxy carbonyl)]propyluridine,orb1908300,Biorbyt
¥0
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AI 赋能培养基定制开发:CHO 培养基是如何实现产量提升Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
详询
- 保质期:
12 months from date of receipt.
- 英文名:
PROTAC PTPN2 degrader-2 TFA
- 库存:
99
- 供应商:
Biorbyt
- CAS号:
2912307-39-0
- 规格:
50 mg/5 mg
| 规格: | 50 mg | 产品价格: | ¥0.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥0.0 |
类别: Small Molecules
描述: PROTAC PTPN2 degrader-2 (example 187B) TFA is a potent and selective degrader of the PTPN2 phosphatase. Its utility in oncology and metabolic disease research is supported by studies demonstrating target degradation in both cellular and in vivo models, offering a tool for investigating these pathways.
靶点: PROTACs,Phosphatase
分子式: C51H50ClF3N6O13S2
分子量: 1111.55
SMILES: C(C(O)=O)(F)(F)F.O=C1C2=C3C(N1[C@@H]4C(=O)NC(=O)CC4)=CC=C(C3=CC=C2)C5CCN(C(NC6=CC(CS(=O)(=O)N7C(C)(C)C[C@@H](NC8=CC(=CC=C8)C9=C(Cl)C(OCC(O)=O)=C(C(O)=O)S9)CC7)=CC=C6)=O)CC5
研究领域: Immunology & Inflammation; Cell Biology, Metabolism Research, Pharmacology & Drug Discovery
保存条件: -20°C
备注: For research use only.
描述: PROTAC PTPN2 degrader-2 (example 187B) TFA is a potent and selective degrader of the PTPN2 phosphatase. Its utility in oncology and metabolic disease research is supported by studies demonstrating target degradation in both cellular and in vivo models, offering a tool for investigating these pathways.
靶点: PROTACs,Phosphatase
分子式: C51H50ClF3N6O13S2
分子量: 1111.55
SMILES: C(C(O)=O)(F)(F)F.O=C1C2=C3C(N1[C@@H]4C(=O)NC(=O)CC4)=CC=C(C3=CC=C2)C5CCN(C(NC6=CC(CS(=O)(=O)N7C(C)(C)C[C@@H](NC8=CC(=CC=C8)C9=C(Cl)C(OCC(O)=O)=C(C(O)=O)S9)CC7)=CC=C6)=O)CC5
研究领域: Immunology & Inflammation; Cell Biology, Metabolism Research, Pharmacology & Drug Discovery
保存条件: -20°C
备注: For research use only.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
解锁蛋白互作可视化新维度:Navinci PLA 技术文献深度盘点
:RIPK1-PROTAC 通过增强免疫原性细胞死亡发挥抗肿瘤作用 文章出处 《A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death 摘要 肿瘤细胞常利用 RIPK1 的支架功能抵抗细胞死亡并逃避免疫监视。研究团队开发了 RIPK1 特异性 PROTAC 降解剂(如 R1-ICR-5),通过降解 RIPK1 解除其对 TNFR1 和 TLR
技术资料暂无技术资料 索取技术资料
PROTAC PTPN2 degrader-2 TFA,orb2278155,Biorbyt
¥0






